Press Releases

Jun 22, 2021

PharmaCyte Biotech Announces Shareholders Vote to Increase the Authorized Capital

Jun 18, 2021

PharmaCyte Biotech Announces Adjournment of Annual Meeting of Stockholders, Recording of Stockholder Meeting Available

Jun 14, 2021

PharmaCyte Biotech Announces Details to Attend This Week’s Virtual Annual Meeting of Shareholders

Apr 1, 2021

PharmaCyte Biotech Successfully Completes 1 Year Stability Study

Jan 26, 2021

PharmaCyte Biotech Begins DNA Sequence and Stability Studies in Response to FDA Requests for its Clinical Trial Product

Dec 14, 2020

PharmaCyte Biotech Begins Physical Testing of CypCaps in Response to FDA Recommendations for its Clinical Trial Product

Dec 2, 2020

PharmaCyte Biotech Successfully Completes 9-Month Stability Study

Nov 4, 2020

PharmaCyte Biotech Receives U.S. FDA Clinical Hold Letter

Oct 2, 2020

PharmaCyte Biotech’s Investigational New Drug Application Placed on Hold by the U.S. FDA

Sep 23, 2020

PharmaCyte Biotech Continues to Engage the FDA During 30-Day Comment Period

« Previous
1
2
3
4
5
6
7
8
9
10
...30
Next »